American Psychiatric Association Annual Meeting, May 17-21, 2025
GHRP-6 GHRP-6 is a growth hormone-releasing peptide studied for its effect on growth hormone pathways
This prevents confusion and ensures consistency across all future doses and follow-up appointments
Thus, development of orally active small molecule GLP-1R modulators remains an attractive strategy and a few compounds have progressed to clinical trials 8
Key findings: Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Unlike GHRP-6, ipamorelin did not stimulate ACTH or cortisol release, even at doses up to 200 times higher than the effective GH-releasing dose Ipamorelin did not significantly increase prolactin levels The GH response was specific and consistent, supporting its classification as the most selective GHRP identified at the time This study established the foundation for all subsequent ipamorelin research and remains one of the most frequently cited papers in the field
Before each injection, patients should inspect the medication visually through the pen's inspection window
.webp)
